SomaLogic: Funding, Investors & Team (Aug 2026)
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.
SomaLogic has raised $375M across 1 funding round on record, the most recent a Post-IPO Equity of $375M announced in Sep 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SomaLogic Company Profile and Key Stats
Latest funding round on record: Sep 2021.
SomaLogic Funding Rounds
SomaLogic Founders and Leadership Team
Contact details for the SomaLogic team: 1 of 1 has an email address on file.
Start 14-day free trial →SomaLogic Funding Compared to Other Biotechnology Startups
SomaLogic's latest round of $375M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SomaLogic in Biotechnology and Boulder
Companies Similar to SomaLogic
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
SomaLogic Funding FAQs
What does SomaLogic do?
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.
How much funding has SomaLogic raised?
SomaLogic has raised $375M across 1 round on record. The most recent is a Post-IPO Equity of $375M announced in Sep 2021.
When did SomaLogic last raise funding?
SomaLogic's most recent funding round on record is a Post-IPO Equity of $375M, announced in Sep 2021.
Who is the CEO of SomaLogic?
Roy Smythe is listed as CEO at SomaLogic.
Where is SomaLogic headquartered?
SomaLogic is based in Boulder, Colorado, United States.
How many employees does SomaLogic have?
SomaLogic is in the 251-500 employee band.
How does SomaLogic's funding compare to other Biotechnology startups?
SomaLogic's latest round of $375M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SomaLogic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SomaLogic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.